Boston Scientific (Brazil) Today
| B1SX34 Stock | BRL 547.43 7.84 1.45% |
Performance19 of 100
| Odds Of DistressLess than 9
|
Boston Scientific is trading at 547.43 as of the 3rd of December 2024, a 1.45% increase since the beginning of the trading day. The stock's open price was 539.59. Boston Scientific has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Boston Scientific are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENDRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. The company has 1.43 B outstanding shares. More on Boston Scientific
Moving together with Boston Stock
| 0.88 | ABTT34 | Abbott Laboratories | PairCorr |
| 0.8 | E1WL34 | Edwards Lifesciences | PairCorr |
| 0.79 | MOAR3 | Monteiro Aranha SA | PairCorr |
Moving against Boston Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Boston Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boston Scientific's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boston Scientific or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Boston Scientific (B1SX34) is traded on Sao Paulo Exchange in Brazil and employs 10 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 358.52 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boston Scientific's market, we take the total number of its shares issued and multiply it by Boston Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boston Scientific operates under Healthcare sector and is part of Medical Devices industry. The entity has 1.43 B outstanding shares.
Boston Scientific has accumulated about 276 M in cash with 1.87 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Check Boston Scientific Probability Of Bankruptcy
Boston Scientific Risk Profiles
Although Boston Scientific's alpha and beta are two of the key measurements used to evaluate Boston Scientific's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8668 | |||
| Semi Deviation | 0.6085 | |||
| Standard Deviation | 1.14 | |||
| Variance | 1.29 |
Boston Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Boston Scientific without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Boston Scientific Corporate Management
Elected by the shareholders, the Boston Scientific's board of directors comprises two types of representatives: Boston Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boston. The board's role is to monitor Boston Scientific's management team and ensure that shareholders' interests are well served. Boston Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boston Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jodi Eddy | VP Officer | Profile | |
| Vance Brown | Gen VP | Profile | |
| Catherine Jennings | VP Interventions | Profile | |
| Joseph Fitzgerald | Ex Cardiology | Profile | |
| John Sorenson | Ex Operations | Profile | |
| Daniel Brennan | Ex CFO | Profile | |
| Jeffrey Mirviss | Ex Interventions | Profile |
Other Information on Investing in Boston Stock
Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.